MLPA has the potential to detect subgroups of IDH-wild-type astrocytoma showing poor prognosis, such as “astrocytoma, grade 4”, but the feasibility of this method needs to be evaluated. Here, IDH1 is linked to astrocytoma (excluding glioblastoma).